Vertex seeks small molecules for RNA in deal with Ribometrix

In Vertex’s latest deal in its recent flurry of M&A activity, the big biotech has partnered with Ribometrix to discover and develop up to three RNA-targeted small molecule programs.

Founded in 2015, Durham, N.C.-based Ribometrix Inc. uses

Read the full 367 word article

How to gain access

Continue reading with a
two-week free trial.